Biological Sciences Division
Published February 1, 2018 | Version v1
Patent Open

USE OF STING AGONIST AS CANCER TREATMENT

Creators

  • 1. University of Chicago

Contributors

Description

Methods and compositions for treating cancer by intratumorally administering a stimulator of interferon genes (STING) agonist are disclosed herein.

Files

US20180028553.pdf

Files (3.3 MB)

Name Size Download all
md5:7cc6b57e3cd5fd6c91497ef018ce1812
3.3 MB Preview Download

Additional details

Identifiers

Patent application number
US 201715783570 A
Patent number
US 2018/0028553 A1
Other
oai:uchicago.tind.io:9462

Dates

Patent filed
2017-10-13

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Pathology, Medicine